Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With Advanced or Metastatic Solid Tumors

NCT00520000 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

47

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

DRUG: Carboplatin
DRUG: Abraxane
DRUG: Abraxane
DRUG: Abraxane

Sponsor

UNC Lineberger Comprehensive Cancer Center

Collaborators

[object Object]